https://www.pharmaceutical-technology.com/data-insights/lb-100-lixte-biotechnology-pleomorphic-liposarcoma-likelihood-of-approval-2/
LB-100 is under clinical development by Lixte Biotechnology and currently in Phase II for Pleomorphic Liposarcoma.
pleomorphic liposarcomalbbiotechnologylikelihood
https://www.livescience.com/47902-rob-ford-what-is-pleomorphic-liposarcoma.html
Toronto Mayor Rob Ford has been diagnosed with an extremely rare and fast-growing tumor.
toronto mayorformerdiesrarecancer